Literature DB >> 7543144

Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.

R Kooijman1, J J Lauf, A C Kappers, G T Rijkers.   

Abstract

Insulin receptor substrate 1 (IRS-1) is the principle cellular substrate for insulin and insulin-like growth factor I (IGF-I) receptor signaling. After phosphorylation of tyrosine residues within the YMXM or YXXM motifs, IRS-1 associates with phosphatidylinositol-3 kinase (PI3K). This signaling pathway and the presence of an IRS-1-like molecule have been demonstrated in IRS-1-transfected and in nontransfected hematopoietic cell lines, respectively. IGF-I has been implicated in lymphocyte development and function, and recently, we showed that functional type-I IGF receptors are present on human thymocytes and peripheral T cells. In this study, we addressed IGF-I signal transduction in nontransformed, freshly isolated, human thymocytes, as well as in blood T cells. Using Western blot analysis, we found that IGF-I induced phosphorylation of a 160-180-kD protein (pp170) in human thymocytes and that phosphorylated pp170 becomes associated with PI3K and is recognized by anti-IRS-1. In blood T cells, this immunoreactive IRS-1 (irIRS-1) is less abundantly expressed than in thymocytes, as assessed with immunoblotting. As a consequence, phosphorylated pp170 was not or hardly detectable after stimulation with IGF-I, and irIRS-1 was not detected in PI3K immunoprecipitates from lysates of IGF-I-stimulated T cells. However, IGF-I induced the tyrosine phosphorylation of other cellular proteins, indicating that differential expression of irIRS-1 contributes to a distinct signaling pathway in T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543144      PMCID: PMC2192136          DOI: 10.1084/jem.182.2.593

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes.

Authors:  R Kooijman; M Willems; G T Rijkers; A Brinkman; S C van Buul-Offers; C J Heijnen; B J Zegers
Journal:  J Neuroimmunol       Date:  1992-05       Impact factor: 3.478

Review 2.  Substrates and signalling complexes: the tortured path to insulin action.

Authors:  R A Roth; B Zhang; J E Chin; K Kovacina
Journal:  J Cell Biochem       Date:  1992-01       Impact factor: 4.429

3.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.

Authors:  X J Sun; P Rothenberg; C R Kahn; J M Backer; E Araki; P A Wilden; D A Cahill; B J Goldstein; M F White
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

4.  Characterization of an endogenous substrate of the insulin receptor in cultured cells.

Authors:  M F White; E W Stegmann; T J Dull; A Ullrich; C R Kahn
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

5.  Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase.

Authors:  L E Samelson; M C Fletcher; J A Ledbetter; C H June
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

6.  Hepatocyte plasma membrane ECTO-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor.

Authors:  R N Margolis; M J Schell; S I Taylor; A L Hubbard
Journal:  Biochem Biophys Res Commun       Date:  1990-01-30       Impact factor: 3.575

7.  Insulin stimulates phosphorylation of a 120-kDa glycoprotein substrate (pp120) for the receptor-associated protein kinase in intact H-35 hepatoma cells.

Authors:  N Perrotti; D Accili; B Marcus-Samuels; R W Rees-Jones; S I Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

Authors:  C H June; M C Fletcher; J A Ledbetter; G L Schieven; J N Siegel; A F Phillips; L E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes.

Authors:  E W Johnson; L A Jones; R W Kozak
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

10.  YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase.

Authors:  S E Shoelson; S Chatterjee; M Chaudhuri; M F White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more
  9 in total

Review 1.  Improving immunity in the elderly: current and future lessons from nonhuman primate models.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Ilhem Messaoudi
Journal:  Age (Dordr)       Date:  2011-12-20

Review 2.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

3.  Listeria monocytogenes produces a pro-invasive factor that signals via ErbB2/ErbB3 heterodimers.

Authors:  Maria José Oliveira; Tineke Lauwaet; Georges De Bruyne; Marc Mareel; Ancy Leroy
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-08       Impact factor: 4.553

Review 4.  The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.

Authors:  Morteza Motallebnezhad; Leili Aghebati-Maleki; Farhad Jadidi-Niaragh; Hamid Nickho; Hosein Samadi-Kafil; Karim Shamsasenjan; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2016-07-21

5.  HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).

Authors:  James J Sollome; Elangovan Thavathiru; Todd D Camenisch; Richard R Vaillancourt
Journal:  Cell Signal       Date:  2013-09-12       Impact factor: 4.315

6.  AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

Authors:  Sarat Chandarlapaty; Ayana Sawai; Maurizio Scaltriti; Vanessa Rodrik-Outmezguine; Olivera Grbovic-Huezo; Violeta Serra; Pradip K Majumder; Jose Baselga; Neal Rosen
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

Review 7.  The insulin-like growth factor pathway as a target for cancer therapy.

Authors:  Iker López-Calderero; Elizabeth Sánchez Chávez; Rocío García-Carbonero
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.340

Review 8.  Review: Metabolic Control of Immune System Activation in Rheumatic Diseases.

Authors:  Andras Perl
Journal:  Arthritis Rheumatol       Date:  2017-11-08       Impact factor: 10.995

9.  MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Authors:  Long Guo; Yu Bai; Tianyu Ni; Yuan Li; Rong Cao; Shuzhe Ji; Shuzhen Li
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.